We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CONE
226
DELISTED
CyrusOne Inc Common Stock
CONE
$12.9M 0.08%
+131,624
New +$11.2M
ORCL icon
227
Oracle
ORCL
$338B
$12.8M 0.08%
147,245
+16,618
+13% +$1.56M
LPX icon
228
Louisiana-Pacific
LPX
$5.19B
$12.8M 0.08%
163,735
-47,107
-22% -$3.23M
KURA icon
229
Kura Oncology
KURA
$783M
$12.7M 0.08%
907,433
-38,924
-4% -$631K
MRSN
230
DELISTED
Mersana Therapeutics
MRSN
$12.6M 0.08%
80,916
– –
AMT icon
231
American Tower
AMT
$80.6B
$12.6M 0.08%
42,931
-45,013
-51% -$12.3M
IBM icon
232
IBM
IBM
$214B
$12.5M 0.08%
93,841
-30,002
-24% -$3.76M
COHR
233
DELISTED
Coherent Inc
COHR
$12.2M 0.08%
45,763
– –
ZTS icon
234
Zoetis
ZTS
$32.9B
$12.1M 0.08%
49,667
-3,513
-7% -$769K
ENTA icon
235
Enanta Pharmaceuticals
ENTA
$361M
$12.1M 0.08%
+161,358
New +$12.7M
SHOP icon
236
Shopify
SHOP
$170B
$12.1M 0.08%
87,400
-65,720
-43% -$9.6M
NTLA icon
237
Intellia Therapeutics
NTLA
$1.5B
$12M 0.08%
101,127
– –
VG
238
DELISTED
Vonage Holdings Corporation
VG
$11.9M 0.08%
+556,276
New +$10.1M
LRCX icon
239
Lam Research
LRCX
$316B
$11.9M 0.08%
164,870
-130,030
-44% -$8.15M
MCO icon
240
Moody's
MCO
$84.4B
$11.8M 0.08%
30,310
-20
-0.1% -$7.71K
DOCU
241
DocuSign
DOCU
$11.1B
$11.6M 0.07%
76,159
+18,400
+32% +$4.19M
MAT icon
242
Mattel
MAT
$4.47B
$11.5M 0.07%
535,016
+17,842
+3% +$374K
UNP icon
243
Union Pacific
UNP
$173B
$11.5M 0.07%
45,480
-18,922
-29% -$4.48M
ZNTL icon
244
Zentalis Pharmaceuticals
ZNTL
$325M
$11.5M 0.07%
136,226
-72,300
-35% -$5.59M
RVMD icon
245
Revolution Medicines
RVMD
$38.1B
$11.3M 0.07%
450,382
-39,000
-8% -$1.1M
CAT icon
246
Caterpillar
CAT
$359B
$11.3M 0.07%
54,741
-3,147
-5% -$634K
T icon
247
AT&T
T
$167B
$11.1M 0.07%
597,883
-11,280
-2% -$211K
ROG icon
248
Rogers Corp
ROG
$2.05B
$11.1M 0.07%
+40,528
New +$9.86M
HUM icon
249
Humana
HUM
$43.8B
$11.1M 0.07%
23,845
+6,037
+34% +$2.67M
DG icon
250
Dollar General
DG
$28.4B
$10.9M 0.07%
46,338
+2,447
+6% +$540K
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.